Used as an intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective modification in drug design, making it valuable in creating compounds that target specific signaling pathways in tumor cells. Commonly employed in research settings for building blocks in heterocyclic chemistry, especially in the preparation of pyrrolopyrimidine-based pharmaceuticals.